Evidence map›Paper›PMID 41740243›Full record

ArticleJACC. Advances2026

Early Response to a Behavioral Community-Based Educational Intervention on Cardiovascular Risk Profile and Well-Being.

Valentí Fuster, Domènec Haro, Xavier Òrrit, Roberto Elosua, Gloria Santos-Beneit, Rodrigo Fernández-Jiménez, Anna Badia, Patricia Bodega, Vanesa Carral, Amaya de Cos-Gandoy and 8 more

Abstract read
In one paragraph

Article in JACC. Advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Valentí FusterCentro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain; Mount Sinai Fuster Heart Hospital, New York, New York, USA; Foundation for Science, Health, and Education (SHE), Barcelona, Spain.
Domènec HaroFoundation for Science, Health, and Education (SHE), Barcelona, Spain.
Xavier ÒrritFoundation for Science, Health, and Education (SHE), Barcelona, Spain.
Roberto ElosuaEGEC Group, Hospital del Mar Research Institute, IMIM, Barcelona, Spain; CIBERCV de Enfermedades Cardiovasculares, Instituto de Salud Carlos III, Madrid, Spain.
Gloria Santos-BeneitCentro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain; Foundation for Science, Health, and Education (SHE), Barcelona, Spain.
Rodrigo Fernández-JiménezCentro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain; CIBERCV de Enfermedades Cardiovasculares, Instituto de Salud Carlos III, Madrid, Spain; Hospital Universitario Clínico San Carlos, IdISSC, Madrid, Spain.
Anna BadiaFoundation for Science, Health, and Education (SHE), Barcelona, Spain.
Patricia BodegaCentro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain; Foundation for Science, Health, and Education (SHE), Barcelona, Spain.
Vanesa CarralFoundation for Science, Health, and Education (SHE), Barcelona, Spain.
Amaya de Cos-GandoyCentro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain; Foundation for Science, Health, and Education (SHE), Barcelona, Spain.
Mercedes de MigueCentro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain; Foundation for Science, Health, and Education (SHE), Barcelona, Spain.
Natalia MontillaFoundation for Science, Health, and Education (SHE), Barcelona, Spain.
Carla RodriguezFoundation for Science, Health, and Education (SHE), Barcelona, Spain.
Isabel CarvajalFoundation for Science, Health, and Education (SHE), Barcelona, Spain.
Carlos PeyraMount Sinai Fuster Heart Hospital, New York, New York, USA; Foundation for Science, Health, and Education (SHE), Barcelona, Spain.
Núria Herrera-MarínREGICOR Group, Hospital del Mar Research Institute, IMIM, Barcelona, Spain.
Anna Camps-VilaróCIBERCV de Enfermedades Cardiovasculares, Instituto de Salud Carlos III, Madrid, Spain; REGICOR Group, Hospital del Mar Research Institute, IMIM, Barcelona, Spain. Electronic address: acamps@researchmar.net.
Jaume MarrugatCIBERCV de Enfermedades Cardiovasculares, Instituto de Salud Carlos III, Madrid, Spain; REGICOR Group, Hospital del Mar Research Institute, IMIM, Barcelona, Spain. Electronic address: jmarrugat@researchmar.net.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiovascular disease is the leading global cause of morbidity and mortality, driven largely by modifiable risk factors. Following the World Health Organization Healthy Cities framework, the Cardona Healthy Community 2030 (HC-2030) intervention was launched in 2021 in Cardona, Spain.

objectivesThis interim analysis evaluates the 2-year dose-response effect of HC-2030 on the Fuster-BEWAT, a score that summarizes several risk factors and behaviors: blood pressure [B], exercise [E], weight [W], alimentation [A], and tobacco [T], score and other cardiovascular risk markers, compared with nonintervened participants from the control town of Sallent.

methodsIn this quasi-experimental study, 1,857 participants aged 12 to 85 years were recruited. HC-2030 included community health-education workshops in Cardona, while Sallent received only usual care and standard prevention advice. Baseline assessments-Fuster-BEWAT score, anthropometrics, behavioral and psychosocial variables, blood pressure, lipid profile, and physical activity-were repeated after 2 years. Dose-response analyses were conducted exclusively in Cardona.

resultsParticipants attending 4 or more workshops showed the greatest improvements in physical activity, adherence to the Mediterranean diet, triglycerides, and diastolic blood pressure. While Fuster-BEWAT scores remained stable in Cardona, they declined significantly in Sallent (-0.06 [95% CI: -0.19 to 0.07] vs -0.50 [95% CI: -0.63 to -0.37] points; P < 0.001). Compared with the control town, the intervention produced 2-year reductions in waist circumference, total cholesterol, and smoking prevalence, together with increases in physical activity and well-being.

conclusionsThe HC-2030 intervention demonstrates the preventive value of community education programs. Consistent participation-at least 4 workshops over 2 years-appears essential to achieve optimal cardiovascular benefits. Continued follow-up will clarify long-term effects.

Indexed as

cardiovascular diseasescommunity health servicesFuster-BEWAT scorehealth educationhealth promotionrisk factors

Identifiers

PMID41740243
PMCPMC12955108

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.